Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Effector hormones

The so-called effector hormones (insulin, glucagon, catecholamines) evoke an extremely fast response. Within a short time, a rapid and lasting redirection of the metabolism can be attained. Catecholamines are degraded in the liver and, following sulphation or glucuronidation, are eliminated as metabolites in either the bile or urine. [Pg.46]

Rao KR (2001) Crustacean pigmentary-effector hormones chemistry and functions of RPCH, PDH, and related peptides. Am Zool 41 364-379... [Pg.430]

Kinins are a group of peptide hormones of 8-11 residues that act locally as proinflammatory agents, often through the release of powerful downstream effectors such as nitric oxide and/or prostaglandins. [Pg.673]

Pertussis toxin is produced by the bacterium Bordetella pertussis. It covalently modifies G-proteins of the G/Go family (transfer of a ADP-ribose moiety of NAD onto G-protein a-subunits). ADP-ribosylated G-proteins are arrested in their inactive state and, as a consequence, functionally uncoupled from their respective effectors. Examples for pertussis toxin-sensitive cellular responses include the hormonal inhibition of adenylyl cyclases, stimulation ofK+ channels, inhibition of Ca2+ channels and stimulation ofthe cGMP-phosphodiesterase in retinal rods. [Pg.946]

The most potent positive allosteric effector of phospho-ffuctokinase-1 and inhibitor of fructose-1,6-bisphos-phatase in liver is fructose 2,6-bisphosphate. It relieves inhibition of phosphofructokinase-1 by ATP and increases affinity for fructose 6-phosphate. It inhibits fructose-1,6-bisphosphatase by increasing the for fructose 1,6-bisphosphate. Its concentration is under both substrate (allosteric) and hormonal control (covalent modification) (Figure 19-3). [Pg.157]

Messenger RNAs exist in the cytoplasm as ribonu-cleoprotein particles (RNPs). Some of these proteins protect the mRNA from digestion by nucleases, while others may under certain conditions promote nuclease attack. It is thought that mRNAs are stabihzed or destabilized by the interaction of proteins with these various structures or sequences. Certain effectors, such as hormones, may regulate mRNA stability by increasing or decreasing the amount of these proteins. [Pg.394]

Receptors are proteins that bind specific hormones and generate an intracellular signal (receptor-effector coupling). [Pg.455]

A G-protein-mediated effect has an absolute requirement for GTP. Reference has already been made to the requirement for GTP in reconstituting hormone-stimulated adenylate cyclase activity. A similar requirement can be demonstrated when the effector is an ion channel, such as the cardiac atrial inward-rectifier K+ channel which is activated following stimulation of the M2 muscarinic acetylcholine receptor. Thus, in the experiment illustrated in Figure 7.8, the channel recorded with a cell-... [Pg.218]

The fluidity of lipid bilayers permits dynamic interactions among membrane proteins. For example, the interactions of a neurotransmitter or hormone with its receptor can dissociate a transducer protein, which in turn will diffuse to interact with other effector proteins (Ch. 19). A given effector protein, such as adenylyl cyclase, may respond differently to different receptors because of mediation by different transducers. These dynamic interactions require rapid protein diffusion within the plane of the membrane bilayer. Receptor occupation can initiate extensive redistribution of membrane proteins, as exemplified by the clustering of membrane antigens consequent to binding bivalent antibodies [8]. In contrast to these examples of lateral mobility, the surface distribution of integral membrane proteins can be fixed by interactions with other proteins. Membranes may also be partitioned into local spatial domains consisting of networks... [Pg.25]

A1 adenosine receptors are inhibitory in the central nervous system. A receptors were originally characterized on the basis of their ability to inhibit adenylyl cyclase in adipose tissue. A number of other G-protein-mediated effectors of A receptors have subsequently been discovered these include activation of K+ channels, extensively characterized in striatal neurons [13], and inhibition of Ca2+ channels, extensively characterized in dorsal root ganglion cells [14]. Activation of A receptors has been shown to produce a species-dependent stimulation or inhibition of the phosphatidylinositol pathway in cerebral cortex. In other tissues, activation of A receptors results in synergistic activation of the phosphatidylinositol pathway in concert with Ca2+-mobilizing hormones or neurotransmitters [15]. The effectors of A adenosine receptors and other purinergic receptor subtypes are summarized in Table 17-2. [Pg.313]

The family of heterotrimeric G proteins is involved in transmembrane signaling in the nervous system, with certain exceptions. The exceptions are instances of synaptic transmission mediated via receptors that contain intrinsic enzymatic activity, such as tyrosine kinase or guanylyl cyclase, or via receptors that form ion channels (see Ch. 10). Heterotrimeric G proteins were first identified, named and characterized by Alfred Gilman, Martin Rodbell and others close to 20 years ago. They consist of three distinct subunits, a, (3 and y. These proteins couple the activation of diverse types of plasmalemma receptor to a variety of intracellular processes. In fact, most types of neurotransmitter and peptide hormone receptor, as well as many cytokine and chemokine receptors, fall into a superfamily of structurally related molecules, termed G-protein-coupled receptors. These receptors are named for the role of G proteins in mediating the varied biological effects of the receptors (see Ch. 10). Consequently, numerous effector proteins are influenced by these heterotrimeric G proteins ion channels adenylyl cyclase phosphodiesterase (PDE) phosphoinositide-specific phospholipase C (PI-PLC), which catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) and phospholipase A2 (PLA2), which catalyzes the hydrolysis of membrane phospholipids to yield arachidonic acid. In addition, these G proteins have been implicated in... [Pg.335]


See other pages where Effector hormones is mentioned: [Pg.172]    [Pg.211]    [Pg.211]    [Pg.31]    [Pg.46]    [Pg.46]    [Pg.423]    [Pg.56]    [Pg.129]    [Pg.172]    [Pg.211]    [Pg.211]    [Pg.31]    [Pg.46]    [Pg.46]    [Pg.423]    [Pg.56]    [Pg.129]    [Pg.555]    [Pg.212]    [Pg.254]    [Pg.6]    [Pg.78]    [Pg.128]    [Pg.1]    [Pg.1241]    [Pg.1241]    [Pg.76]    [Pg.387]    [Pg.435]    [Pg.435]    [Pg.458]    [Pg.459]    [Pg.460]    [Pg.460]    [Pg.460]    [Pg.124]    [Pg.83]    [Pg.87]    [Pg.104]    [Pg.238]    [Pg.102]    [Pg.283]    [Pg.11]    [Pg.148]    [Pg.105]    [Pg.532]   
See also in sourсe #XX -- [ Pg.46 ]




SEARCH



Coupling hormone receptor-effector

Effector

Hormone receptor-effector systems

Hormone-like regulatory effector

Hormones effector systems

© 2024 chempedia.info